190 related articles for article (PubMed ID: 17668897)
1. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15.
Gill N; Ashkar AA
Eur J Immunol; 2007 Sep; 37(9):2529-38. PubMed ID: 17668897
[TBL] [Abstract][Full Text] [Related]
2. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
3. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus.
Tsunobuchi H; Nishimura H; Goshima F; Daikoku T; Suzuki H; Nakashima I; Nishiyama Y; Yoshikai Y
Virology; 2000 Sep; 275(1):57-66. PubMed ID: 11017787
[TBL] [Abstract][Full Text] [Related]
4. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
5. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2.
Gill N; Ashkar AA
J Virol; 2009 Jan; 83(2):918-26. PubMed ID: 19004955
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
Milligan GN; Dudley-McClain KL; Chu CF; Young CG
Virology; 2004 Jan; 318(2):507-15. PubMed ID: 14972519
[TBL] [Abstract][Full Text] [Related]
8. NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection.
Gill N; Chenoweth MJ; Verdu EF; Ashkar AA
Cell Immunol; 2011; 269(1):29-37. PubMed ID: 21477795
[TBL] [Abstract][Full Text] [Related]
9. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
Kwant A; Rosenthal KL
Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061
[TBL] [Abstract][Full Text] [Related]
10. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
11. Estradiol limits viral replication following intravaginal immunization leading to diminished mucosal IgG response and non-sterile protection against genital herpes challenge.
Gillgrass A; Chege D; Bhavanam S; Kaushic C
Am J Reprod Immunol; 2010 Apr; 63(4):299-309. PubMed ID: 20070285
[TBL] [Abstract][Full Text] [Related]
12. A regulatory role of interleukin 15 in wound healing and mucosal infection in mice.
Kagimoto Y; Yamada H; Ishikawa T; Maeda N; Goshima F; Nishiyama Y; Furue M; Yoshikai Y
J Leukoc Biol; 2008 Jan; 83(1):165-72. PubMed ID: 17906118
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice.
Del Campo J; Lindqvist M; Cuello M; Bäckström M; Cabrerra O; Persson J; Perez O; Harandi AM
Vaccine; 2010 Feb; 28(5):1193-200. PubMed ID: 19945418
[TBL] [Abstract][Full Text] [Related]
14. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
Milligan GN; Bernstein DI; Bourne N
J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
[TBL] [Abstract][Full Text] [Related]
15. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge.
Morrison LA; Da Costa XJ; Knipe DM
Virology; 1998 Mar; 243(1):178-87. PubMed ID: 9527927
[TBL] [Abstract][Full Text] [Related]
16. Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone.
Bhavanam S; Snider DP; Kaushic C
Vaccine; 2008 Nov; 26(48):6165-72. PubMed ID: 18804503
[TBL] [Abstract][Full Text] [Related]
17. A critical role for IL-15 in TLR-mediated innate antiviral immunity against genital HSV-2 infection.
Thatte A; DeWitte-Orr SJ; Lichty B; Mossman KL; Ashkar AA
Immunol Cell Biol; 2011 Aug; 89(6):663-9. PubMed ID: 21339766
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
Lee AJ; Ashkar AA
Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
[TBL] [Abstract][Full Text] [Related]
19. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
Gillgrass AE; Tang VA; Towarnicki KM; Rosenthal KL; Kaushic C
J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
[TBL] [Abstract][Full Text] [Related]
20. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
